General Information of Drug (ID: DMAKP20)

Drug Name
eicosatetranoic acid Drug Info
Synonyms
ETYA; 5,8,11,14-eicosatetraynoic acid; 1191-85-1; icosa-5,8,11,14-tetraynoic acid; Octadehydroarachidonic acid; eicosatetranoic acid; MLS000069514; SMR000058640; MLS-0002886.0001; Ro 31428; Ro 3-1428; Opera_ID_402; AC1Q5VYB; Spectrum5_001952; cid_1780; CBiol_001864; SCHEMBL68751; KBioSS_000169; BSPBio_001449; KBioGR_000169; GTPL2669; CHEMBL458328; BML2-F04; AC1L1C80; CTK0H5766; CHEBI:94483; KBio3_000338; KBio2_002737; KBio3_000337; KBio2_005305; KBio2_000169; BDBM31752; DTXSID20152318; MGLDCXPLYOWQRP-UHFFFAOYSA-N; HMS3402I11; Bio1_001128
Cross-matching ID
PubChem CID
1780
ChEBI ID
CHEMBL458328
CAS Number
CAS 1191-85-1
TTD Drug ID
D0G9IP

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Proteasome 2.50 0.00e+0 44/46 (95.65%) PSMB3;PSMD2;PSMC4;...
Huntington disease 2.18 0.00e+0 233/306 (76.14%) NDUFB1;COX7B;PSMB3;...
Oxidative phosphorylation 2.17 0.00e+0 93/133 (69.92%) COX17;NDUFB1;COX7B;...
DNA replication 1.98 0.00e+0 34/36 (94.44%) RPA3;RFC4;POLE2;...
Prion disease 1.96 2.50e-3 209/273 (76.56%) NDUFB1;COX7B;PSMB3;...
Thermogenesis 1.93 2.08e-3 173/232 (74.57%) COX17;NDUFB1;COX7B;...
Amyotrophic lateral sclerosis 1.93 1.79e-3 267/364 (73.35%) PFN2;NDUFB1;COX7B;...
Parkinson disease 1.87 5.47e-3 176/249 (70.68%) NDUFB1;COX7B;PSMB3;...
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis 1.75 1.39e-2 20/26 (76.92%) PIGT;GPAA1;PIGP;...
Diabetic cardiomyopathy 1.74 1.25e-2 162/203 (79.8%) NDUFB1;COX7B;NDUFA4;...
Spinocerebellar ataxia 1.68 2.90e-2 128/143 (89.51%) PSMB3;PSMD2;PSMC4;...
Valine, leucine and isoleucine degradation -1.77 4.61e-2 42/48 (87.5%) AUH;DBT;ACAA1;...
Glycine, serine and threonine metabolism -1.80 4.07e-2 31/40 (77.5%) AGXT;DAO;MAOA;...
Fructose and mannose metabolism -1.81 4.97e-2 30/33 (90.91%) FBP2;HK3;ALDOB;...
Tyrosine metabolism -1.94 6.78e-3 30/36 (83.33%) GOT1;DDC;MAOA;...
Glycolysis / Gluconeogenesis -1.99 1.36e-2 56/67 (83.58%) GCK;ADH7;PDHA2;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Fibroblast
Nasopharyngeal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
FIBRNPC CVCL_UK07 Homo sapiens 10uM 6H, 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
1HAEo- CVCL_0128 Homo sapiens 10uM 24H
NL20 CVCL_0461 Homo sapiens 10uM 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H
Normal (Fibroblast)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HFL1 CVCL_4295 Homo sapiens 10uM 24H
IMR-90 CVCL_0347 Homo sapiens 10uM 24H
WI-38 CVCL_0579 Homo sapiens 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H